AN ACT CONCERNING PUBLIC DISCLOSURE OF CERTAIN INFORMATION REGARDING PHARMACEUTICAL REPRESENTATIVES.

SB 969 eliminates a requirement for Connecticut's Department of Consumer Protection to prominently post a list of pharmaceutical representatives' information on its website. The bill removes the existing mandate under section 21a-70i of the general statutes that previously required this public disclosure. This change directly affects the Department of Consumer Protection, which would no longer need to maintain and display this specific list online. The bill focuses solely on removing an administrative posting obligation, with no new provisions or policy changes for pharmaceutical companies or the public.